Intestinal remodeling during *Xenopus* metamorphosis is an excellent model to study the development of adult organ-specific stem cells ([@B1]). In the South African clawed frog *Xenopus laevis* and the highly related species *Xenopus tropicalis*, the larval intestine is a simple tubular structure consisting of a single layer of primary epithelium and thin layers of connective tissue and muscles. This simple structure is transformed into a complex one consisting of a multifolded adult epithelium surrounded by well-developed connective tissue and muscles ([@B3]), which resembles the adult mammalian intestine ([@B5]). The remodeling of the intestine during *Xenopus* metamorphosis involves the degeneration of the larval epithelium through programmed cell death or apoptosis and concurrent *de novo* formation of the adult intestinal stem cells, which eventually give rise to the adult epithelium.

Similar to other processes during amphibian metamorphosis, intestinal remodeling, including the formation of the adult stem cells, is controlled by thyroid hormone (T3). It can be easily manipulated by controlling the availability of T3 in tadpoles or even in tadpole intestinal organ cultures ([@B5]). Taking advantages of this model system, we and others have previously demonstrated that some cells in the larval intestinal epithelium dedifferentiate to form the adult stem cells in the presence of T3 through yet unknown mechanism ([@B3]). Furthermore, recombinant intestinal organ culture studies using wild-type and transgenic tadpoles expressing a dominant-positive T3 receptor (TR) under the control of a heat shock--inducible promoter have revealed that T3 can induce some cells within the larval epithelium to undergo tissue-autonomous dedifferentiation into a precursor form that express sonic hedgehog, which is expressed in intestinal stem cells, but not Musashi-1, a known stem cell marker of adult mammalian intestine ([@B13]). The development of the adult stem cells requires T3 signaling in both the epithelium and the rest of the intestinal tissues, most likely the connective tissue underlying the epithelium ([@B11]).

T3 is known to regulate metamorphosis by regulating gene expression through TRs, which regulate the expression of T3-inducible genes in a T3-dependent manner as heterodimers with 9-*cis* retinoic acid receptors (RXRs) ([@B18]). Thus, we have recently carried out genome-wide microarray analyses to identify genes that are regulated by T3 in the epithelium and the rest of the intestine during metamorphosis ([@B21]). Of particular interests are those genes that are highly expressed specifically in the intestinal epithelium at the climax of metamorphosis when adult stem cells are forming and proliferating. Such genes are likely to be involved in stem cell development. Among the genes with peak level expression in the intestine at the climax of metamorphosis is a *Xenopus* homolog of the mammalian histidine ammonia-lyase (HAL) gene ([@B26]). The mammalian HAL encodes a cytosolic enzyme known as histidase or histidinase. Histidase catalyzes the nonoxidative deamination of [l]{.smallcaps}-histidine to *trans*-urocanic acid and ammonia (<http://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=ShowDetailView&TermToSearch=3034>), the first step in histidine catabolism ([@B27]). Histidase deficiency in human leads to histidinemia or histidinuria. Children with histidinemia often have hyperactivity, speech impediment, developmental delay, learning difficulties, and sometimes mental retardation (<http://en.wikipedia.org/wiki/Histidinemia>) ([@B30]). The mechanisms underlying the histidase deficiency--mediated pathogenesis and what roles HAL plays during development remain to be investigated.

Whereas only a single HAL gene is found in mammals, two HAL genes are present in *X. laevis* and *X. tropicalis* due to a gene duplication event after the separation of amphibians from mammals ([@B26]). Our earlier studies have shown that the two HAL genes are regulated in a tissue- and gene-dependent manner in the intestine. At the whole animal level, HAL1 is expressed during embryogenesis whereas HAL2 is expressed during metamorphosis. Importantly, in the intestine, HAL2 has no detectable expression before or after metamorphosis, but its messenger RNA (mRNA) level is highly upregulated at the climax of metamorphosis, specifically in the newly formed proliferating adult stem cells. Furthermore, HAL2 expression can be induced when premetamorphic tadpoles are treated with T3, suggesting that T3 regulates the transcription of HAL2 ([@B26]). In this study, we report the identification of a T3 response element (TRE) in the HAL2 gene that can bind to TR/RXR heterodimers *in vitro* and mediate T3-induced transcription in the frog oocyte transcription system. More importantly, we demonstrate that the HAL2 TRE is bound by TR in the intestine during metamorphosis and that a TRE-containing HAL2 promoter fragment can drive reporter gene expression in a T3-dependent manner in transgenic tadpoles that mimics the endogenous HAL2 expression. Thus, the HAL2 TRE likely mediates the induction of HAL2 gene by T3 in the developing adult intestinal stem cells during development.

Materials and Methods {#s1}
=====================

Animals and treatments {#s2}
----------------------

Wild-type *X. laevis or X. tropicalis* tadpoles were reared in the laboratory or purchased from Nasco (Fort Atkinson, MI) and *Xenopus* I (Dexter, MI). Premetamorphic tadpoles at stage 54 ([@B35]) were treated with 10 nM T3 for 1 to 5 days. At least three tadpoles were analyzed for each stage or day of T3 treatment. All studies were performed as approved by the National Institute of Child Health and Human Development Animal Use and Care Committee.

Cloning of HAL2 promoter {#s3}
------------------------

The *X. tropicalis* HAL2 promoter region was first polymerase chain reaction (PCR) amplified using primers 5′-GTACCCTGCGTCGTGTACGTACACGGAG-3′ and 5′-GCTAACCATTCTCCTCGCACATGCACTG-3′. The PCR product was used for the nested PCR with primers 5′-GTCTG**GGTACC**CCTGAAATAAACAAACTAAAAGCATAC-3′ (bearing a *Kpn*I site in bold letters) and 5′-GGGG**ACCGGT**TCCAACTGATTCAAAAGATATGGTGCTCTG-3′ (bearing an *Age*I site in bold letters). The PCR product was digested with *Kpn*I and *Age*I, and cloned into AcGFP1.1 vector (Clontech).

Generation of HAL2 promoter construct for transgenesis {#s4}
------------------------------------------------------

The 4.4-kb HAL2 promoter in AcGFP1.1 above was subcloned into the *Kpn*I-*Age*I digested double-promoter construct (pDPCG-SceI, a gift from Dr. D.R. Buchholz) ([@B36]) to produce a transgenic construct with the HAL2 promoter driving enhanced green fluorescent protein (EGFP) expression and the *γ*-crystallin promoter driving GFP3 in the eyes of the animals, which allows easy identification of transgenic tadpoles \[see [Fig. 2(b)](#F2){ref-type="fig"}\] ([@B38]).

Generation of luciferase report constructs for transcription assay {#s5}
------------------------------------------------------------------

The promoter constructs harboring pHAL2-TRE-luc or pHAL2-mtTRE-luc were generated through PCR-mediated mutagenesis on a firefly luciferase reporter construct containing *X*. tropicalis Dot1L promoter with mutant TREs \[pmTRE(Dot1L)-luc\] ([@B40]). The pHAL2-TRE-luc construct was made with primer set 1, 5′-TGTTGGATGCTCATACTCGTCC-3′ (LZ631) and 5′-GCGGGAGGTCACCTGAGGTTGCTTAGCCTGAAGTCTGAGG-3′ (HAL2TRE_R), and primer set 2, 5′-CTAAGCAACCTCAGGTGACCTCCCGCGGGATTATTTATTTTATTC-3′ (HAL2TRE_F) and 5′-GGTAATGTCCACCTCGATATGTGC-3′ (LZ632), in two different PCR reactions to produce 1034-bp and 510-bp fragments, respectively. The two PCR fragments were gel purified and then mixed together as templates in a second round of PCR with primers LZ631 and LZ632 to produce an ∼1.5-kb fragment. The 1.5-kb fragment was then subjected to restriction enzyme digestion with *Kpn*I and *Hin*dIII. The 1048-bp restricted fragment was then subcloned into *Kpn*I-*Hin*dIII digested firefly luciferase reporter construct pmTRE(Dot1L)-luc, whereby the Dot1L mTRE in pmTRE(Dot1L)-luc was replaced with HAL2 TRE. The pHAL2-mtTRE-luc construct was made similarly with the primers 5′-GCGGGAAATCACCTGAAGTTGCTTAGCCTGAAGTCTGAGG-3′ (HAL2-mtTRE_R) and 5′-CTAAGCAACTTCAGGTGATTTCCCGCGGGATTATTTATTTTATTC-3′ (HAL2-mtTRE_F), which were used to replace the HAL2TRE_R and HAL2TRE_F, respectively, in the initial two PCR reactions.

Gel mobility shift assay {#s6}
------------------------

This was done as described ([@B41]). Briefly, *X. laevis* TR*α* and RXR*α* proteins were made using a TNT SP6 quick coupled transcription/translation system (Promega, Madison, WI). The proteins were mixed with the probe \[an infrared dye IR700 (LI-COR Biosciences, Lincoln, NE)--labeled TRE of the *X. laevis* TR*β* gene\] in the *in vitro* binding reaction in the presence or absence of unlabeled competitors. Sequences of the sense strand of unlabeled competitor oligonucleotides are as follows: 5′-tgaattg**CAACCT**cagg**TGACCT**gtctggt-3′ for HAL2 TRE, 5′-tgaattg**CAAC[T]{.ul}T**cagg**TGA[TT]{.ul}T**gtctggt-3′ for mutant HAL2 TRE, 5′-cctaggc**AGGTCA**tttc**AGGACA**gcccagc-3′ for TR*β* TRE, and 5′-cctaggc**AGGTCA**tttc**A[AA]{.ul}ACA**gcccagc-3′ for mutant TR*β* TRE (the TRE half sites are in bolded uppercase letters, and the mutated nucleotides are underlined). Each binding reaction included 1μL (100 fmol) of IR700-labeled probe, 1 μL of each *in vitro*--translated TR and RXR protein, and 1 μL at 1 pmol/μL or 10 pmol/μL of indicated unlabeled competitors to obtain 10× or 100× unlabeled competitor oligonucleotides, in a total volume of 20 μL. The mixtures were incubated at room temperature for 20 minutes, electrophoresed on a 6% DNA retardation gel (Invitrogen), and then scanned by using an Odyssey infrared scanner (LI-COR Biosciences).

Transcription assay in the *X. laevis* oocyte system {#s7}
----------------------------------------------------

The plasmids containing *X. laevis* TR*α* and RXR*α* were linearized and transcribed *in vitro* using an mMESSAGE mMACHINE Sp6 transcription kit (Ambion, Austin, TX). The cytoplasm of stage VI oocytes from *X. laevis* was injected with 46 pg per oocyte of the GFP mRNA or TR and RXR mRNAs. Two hours later, the firefly luciferase reporter (345 pg per oocyte), either pTRE(HAL2)-luc or pTRE(TR*β*)-luc, and the control phRG-TK *Renilla* luciferase (Promega) (34.5 pg per oocyte) were coinjected into the oocyte nucleus. After overnight incubation at 18°C in the presence or absence of 100 nM T3, the injected oocytes were prepared for luciferase assay by using the Dual-Luciferase reporter assay system according to the manufacturer's protocol (Promega). Three oocytes per sample were lysed in 45 μL of 1× passive buffer (Promega), and 10 μL of lysate was used for the luciferase assays. Three independent samples were done for each injection at the same time. The relative expression of firefly luciferase to *Renilla* luciferase was determined. Each data point represents the average of the five samples with the standard error.

Quantitative reverse transcription PCRs {#s8}
---------------------------------------

Total RNA was isolated from the tadpole small intestine by using the Direct-zol RNA MiniPrep kit (Zymo Research, Irvine, CA) according to the manufacturer's protocol. The cDNA was synthesized with 1 μg of total RNA in 20 μL of reaction using the QuantiTect reverse transcription kit (Qiagen, Germantown, MD) according to the manufacturer's protocol. Diluted cDNA (2 μL) was subjected to quantitative reverse transcription PCR (qRT-PCR) by using SYBR Green PCR master mix (Applied Biosystems, Foster City, CA) in a 20-μL reaction. The qRT-PCR was done by using the StepOnePlus real-time PCR system (Applied Biosystems), according to the manufacturer's protocol. The primers used were forward 5′-AGCTGCTCACAGGTTGCTAGTT-3′ and reverse 5′-AAGAGTCCAATGAAAAAGATGTA-3′ for *X. laevis* HAL2, forward 5′-TGCATTCTGCCACCTAGTCG-3′ and reverse 5′-GGCAAAGGTAACCACCATGC-3′ for *X. laevis* elongation factor-1*α* (EF1*α*), forward 5′-GCCAACACTTGTCACTACTTTTACG-3′ and reverse 5′-ACGTGTCTTGTAGTTCCCGTCATCT-3′ for transgenic EGFP, forward 5′-TGAGACCCCATCCTGGACAAGTG-3′ and reverse 5′-GAACAGCACCGTAGTGTATAAGCA-3′ for *X. tropicalis* HAL2, and forward 5′-CGGAACTACCCTGCTGGAAG-3′ and reverse 5′-GGCAAAGGTAACCACCATGC-3′ for *X. tropicalis* EF1*α*. The level of HAL2 and transgenic EGFP mRNA was normalized against the level of EF1*α* mRNA for each sample. Each data point represents the average of the three samples with the standard error. Each experiment was repeated at least twice.

Chromatin immunoprecipitation assay {#s9}
-----------------------------------

A chromatin immunoprecipitation (ChIP) assay on tadpole intestine was performed as descried with anti-TR antibody (new PB) ([Table 1](#T1){ref-type="table"}) ([@B24]). A polyclonal antibody against Id14, an extracellular protein, was used as a negative control ([Table 1](#T1){ref-type="table"}) ([@B24]). Each treatment or control group had three replicas, and each replica consisted of six to eight tadpoles. The chromatins for ChIP assay were fragmented to be ∼500 bp by sonication. The immunoprecipitated DNA was analyzed by quantitative PCR using the following primers: 5′-CCTGTGGCAGTGCGGGTCAG-3′ (KF403) and 5′-ACAGCCCAACCAGACAGGTCAC-3′ (KF404) for the TRE region of *X. tropicalis* HAL2 gene, and 5′-CAGCAGGTCTACAACCACTCTG-3′ (KF395) and 5′-TGAATCTTACCACTTCCCAGGT-3′ (KF396) for the exon 5 region of *X. tropicalis* Dot1L gene ([@B41]).

###### 

**Antibodies Used**

  **Peptide/** **Protein Target**   **Antigen Sequence** **(if Known)**    **Name of**  **Antibody**   **Manufacturer, Catalog No., and/or Name of Individual Providing the Antibody**   **Species Raised in; Monoclonal or Polyclonal**   **Dilution Used**
  --------------------------------- -------------------------------------- --------------------------- --------------------------------------------------------------------------------- ------------------------------------------------- -------------------
  ID14                              DKVTPKKDDGATS-KLH, ETKCRCNMDGDVE-MAP   Anti-ID14                   Buchholz *et al.* ([@B43])                                                        Rabbit polyclonal                                 2:125
  TR                                Recombinat xlTRb protein               Anti-TR new PB              Wang *et al.* ([@B42])                                                            Rabbit polyclonal                                 2:125

*In situ* hybridization {#s10}
-----------------------

A partial cDNA encoding EGFP was PCR amplified and cloned into pCRII-TOPO (Invitrogen, Carlsbad, CA) as previously described ([@B44]). To synthesize the antisense RNA probe, the plasmid was linearized with *Bam*HI and transcribed with T7 RNA polymerase (Roche Applied Science, Indianapolis, IN); to synthesize the sense RNA probe, the plasmid was linearized with *Xba*I and transcribed with SP6 RNA polymerase (Roche Applied Science). *In situ* hybridization on frozen cross-sections of intestines from tadpoles at the climax of metamorphosis was performed as described previously with probe concentrations at 2 μg/mL ([@B26]). Both the sense and the antisense RNA probes were labeled with digoxin. The hybridized probe was detected with alkaline phosphatase-coupled anti-digoxin antibody and visualized with color development of 5-bromo-4-chloro-3-indolyl-phosphate/nitro blue tetrazolium on alkaline phosphatase activity (GE Health, Pittsburgh, PA). Images were taken by using a digital CCD color camera (Retiga EXi; QImaging, British Columbia, Canada) attached to an optical microscope (BX60; Olympus, Waltham, MA).

Results {#s11}
=======

The *X.* *tropicalis* HAL2 is highly upregulated by T3 during intestinal metamorphosis {#s12}
--------------------------------------------------------------------------------------

We first investigated whether the *X. tropicalis* HAL2 gene is regulated similarly as the *X. laevis* HAL2 gene during intestinal metamorphosis. Total RNA was isolated from whole intestine of tadpoles at premetamorphosis (stage 54), prometamorphosis (stages 56, 58), climax (stages 61, 64), and the end of metamorphosis (stage 66) and subjected to qRT-PCR analysis for HAL2 expression. Exactly as in *X. laevis*, the HAL2 mRNA levels were low in premetamorphic and prometamorphic tadpole intestine (stages 54 to 58) but were strongly upregulated at climax (stages 61 to 64) when adult stem cells are forming and proliferating in the intestine ([@B1]) \[[Fig. 1(a)](#F1){ref-type="fig"}\]. By the end of the metamorphosis (stage 66) when adult intestine is formed, the HAL2 mRNA level was reduced again. Additionally, when premetamorphic stage 54 tadpoles were treated with 10 nM T3 for 2 days, the HAL2 mRNA level in the intestine was found to be highly upregulated \[[Fig. 1(b)](#F1){ref-type="fig"}\], again mimicking the pattern in *X. laevis*. Thus, HAL2 regulation during intestinal metamorphosis is conserved between *X. laevis* and *X. tropicalis*.

![*X. tropicalis* HAL2 is strongly upregulated by T3 at the climax of intestinal metamorphosis when adult stem cells are forming and proliferating. (a) HAL2 expression peaks at the climax of natural metamorphosis. Total RNA was isolated from whole intestine of tadpoles at premetamorphosis (stage 54), prometamorphosis (stages 56, 58), climax (stages 61, 64), and at the end of metamorphosis (stage 66) and subjected to qRT-PCR analysis for HAL2 expression. Note that HAL2 levels were high at the climax. (b) HAL2 expression is induced by T3 treatment of premetamorphic tadpoles. Premetamorphic stage 54 tadpoles were treated with 10 nM T3 for 2 days. Total RNA was isolated from the whole intestine and subjected to qRT-PCR analysis for HAL2 expression.](en.2016-1558f1){#F1}

The *X.* *tropicalis* HAL2 gene contains a functional TRE {#s13}
---------------------------------------------------------

The induction of HAL2 gene by T3 treatment of premetamorphic tadpoles suggests that the HAL2 gene may be a stem cell--specific gene induced by T3 directly at the transcriptional level. To investigate this possibility, we took advantage of the availability of the sequenced *X. tropicalis* genome to search for potential TREs around predicted promoter region of the HAL2 gene. This is possible because of the conservation between *X. laevis* and *X. tropicalis*, where all known T3-regulated genes that have been studied in both species have conserved spatiotemporal expression patterns ([@B6]). Bioinformatics analysis (NHR SCAN: <http://www.cisreg.ca/cgi-bin/NHR-scan/nhr_scan.cgi>) revealed the existence of a single putative TRE located ∼3.1 kb upstream of the putative transcription start site \[[Fig. 2(a)](#F2){ref-type="fig"}\]. The TRE is highly homologous to the consensus TRE made of two direct repeats of AGGTCA separated by 4 bp. To investigate the function of the putative TRE, we first carried out a gel mobility shift assay by using *in vitro*--translated TR/RXR and labeled *X. laevis* TR*β* TRE \[[Fig. 2(b)](#F2){ref-type="fig"}\], a well-characterized, strong TRE ([@B50]). As shown in [Fig. 2(c)](#F2){ref-type="fig"}, the labeled TR*β* TRE formed a complex with TR/RXR, and this complex was effectively competed away by the unlabeled TR*β* TRE but not a mutant TR*β* TRE. Importantly, the HAL2 TRE was also able to compete effectively, with similar affinity as the TR*β* TRE \[[Fig. 2(c)](#F2){ref-type="fig"}\]. Alternatively, introducing three base substitutions in the HAL2 TRE (mtTRE) abolished its ability to compete \[[Fig. 2(c)](#F2){ref-type="fig"}\]. Thus, the HAL2 TRE binds to TR/RXR heterodimers with similar affinity as the well-known TR*β* TRE.

![The HAL2 TRE binds to TR/RXR *in vitro*. (a) Intron--exon organization of the HAL2 gene. The +1 indicates putative transcription start site based on reported cDNA sequence. A putative TRE is present at −3091 to −3076 with the half TRE repeat shown in capital letters. The exons are shown in filled boxes whereas the introns and upstream sequences are shown as lines. The open box represents the HAL2 TRE. (b) Sequences of wild-type and mutant (mt) TRE of *X. tropicalis* HAL2 and *X. laevis* TR*β* genes. The sequences of the TRE half sites are shown in capital letters with the mutated residues in the mutant TREs underlined. (c) Wild-type (wt) but not mutant (mt) HAL2 TRE (H2 TRE) competes effectively for binding to TR/RXR *in vitro*. Gel mobility shift assay was carried out with labeled wild-type *X. laevis* TR*β* TRE and *in vitro*--translated TR/RXR in the presence or absence of 10 to 100× excess unlabeled wild-type or mutant TREs as indicated. Note that as expected, the complex formed between the labeled, well-characterized *X. laevis* TR*β* TRE and TR/RXR was competed effectively by the unlabeled wild-type but not the mutant TR*β* TRE. Similarly, the wild-type but not the mutant HAL2 TRE was able to compete effectively, indicating that HAL2 TRE binds to TR/RXR with similar affinity as the TR*β* TRE.](en.2016-1558f2){#F2}

We next investigated whether the HAL2 TRE could mediate transcriptional activation of a reporter gene by liganded TR/RXR in the reconstituted *X. laevis* oocyte transcription system ([@B42]), where the reporter plasmid injected into the oocyte nucleus is chromatinized. We have shown earlier that a TRE located ∼1 kb or more from the transcription start site has little effect on the promoter activity in this *in vivo* system ([@B52]). Because the HAL2 TRE is \>3 kb away from the putative start site, we could not study the function of the TRE in its native promoter. Thus, we chose to investigate its function in a reporter promoter. We have shown previously that the *X. tropicalis* Dot1L promoter is regulated by TR/RXR in a T3-dependent manner in the reconstituted frog oocyte system ([@B40]). Furthermore, this regulation depends on the presence of a Dot1L TRE ([@B40]). Thus, we replaced the Dot1L TRE with HAL2 TRE or mtTRE in the Dot1L reporter construct to obtain the HAL2 reporter constructs pHAL2-TRE-luc and pHAL2-mtTRE-luc, respectively \[[Fig. 3(a)](#F3){ref-type="fig"}\]. When the reporter construct pHAL2-TRE-luc was injected into the frog oocyte nucleus, it was regulated by T3 when TR/RXR were introduced into the oocyte via injection of their mRNAs into the oocyte cytoplasm \[[Fig. 3(b)](#F3){ref-type="fig"}\]. However, when the reporter construct pHAL2-mtTRE-luc was injected to the oocyte nucleus, it was not regulated by T3 even in the presence of TR/RXR, indicating that the HAL2 TRE is capable of, and required for, mediating transcriptional regulation by TR/RXR in a T3-dependent manner.

![The HAL2 TRE mediates transcriptional activation by T3 in frog oocytes. (a) Schematic diagram of promoter constructs pHAL2-TRE-luc (HAL2-TRE) and pHAL2-mtTRE-luc (HAL2-mtTRE) containing the wild-type and mutated HAL2 TRE, respectively. (b) The luciferase reporter construct pHAL2-TRE-luc (HAL2-TRE) or pHAL2-mtTRE-luc (HAL2-mtTRE) was coinjected with the control *Renilla* luciferase construct phRG-tk into the nuclei of *Xenopus* oocytes with or without prior cytoplasmic injection of *X. laevis* TR*α* and RXR*α* mRNAs. The oocytes were incubated at 18°C overnight in the presence or absence of 100 nM T3 and then used for Dual-Luciferase assays. The relative activities of the firefly luciferase to *Renilla* luciferase were plotted. Note that the reporter with the wild-type but not the mutated HAL2 TRE responded to T3 in the presence of TR/RXR.](en.2016-1558f3){#F3}

The *X.* *tropicalis* HAL2 TRE is bound by TR in tadpole intestine {#s14}
------------------------------------------------------------------

To determine whether the HAL2 TRE is responsible for the regulation of the HAL2 gene by T3 during intestinal metamorphosis, we used a ChIP assay to investigate the binding of the TR to the HAL2 TRE in the intestine of premetamorphic *X. tropicalis* tadpoles treated with or without T3. As shown in [Fig. 4](#F4){ref-type="fig"}, TR was found to be present at the HAL2 TRE in premetamorphic intestine, and its association was increased upon T3 treatment of premetamorphic tadpoles. In contrast, there were only very low, background signals at the exon 5 of the Dot1L gene, which lacks any TRE ([@B41]). Additionally, only background signals were observed at either the HAL2 TRE and Dot1L exon 5 when ChIP assay was done with an antibody against ID14, an extracellular protein ([@B43]) ([Fig. 4](#F4){ref-type="fig"}), confirming the specificity of the TR ChIP signal at the HAL2 TRE. Thus, the HAL2 TRE is bound by TR in tadpole intestine and likely mediates the induction of the HAL2 gene by T3 in the intestinal epithelium during metamorphosis.

![The HAL2 TRE is bound by TR in tadpole intestine. Stage 54 premetamorphic tadpoles were treated with or without T3 for 2 days, and the intestine was isolated for ChIP assay with the anti-TR antibody (top) or anti-ID14 antibody (bottom), which served as a negative control for antibody specificity. The immunoprecipitated DNA was analyzed by qPCR for the presence of the TRE region of HAL2 promoter. A region of the exon 5 in the Dot1L gene with no TRE ([@B41]) was analyzed as a negative control for binding specificity. Note that TR binding to the HAL2 TRE was increased upon T3 treatment. There was no TR binding to Dot1L exon 5 in the presence or absence of T3 and only background signals were observed with the anti-ID14 antibody.](en.2016-1558f4){#F4}

Transgenic EGFP under the control of the *X.* *tropicalis* HAL2 promoter is regulated by T3 and mimics the endogenous HAL2 gene {#s15}
-------------------------------------------------------------------------------------------------------------------------------

To determine whether the HAL2 promoter is indeed regulated by TR during intestinal metamorphosis, we next used transgenesis to investigate whether the HAL2 promoter can drive transgenic EGFP expression in a T3-dependent manner *in vivo*. We generated a double promoter transgenic construct, in which the first promoter, a 4.5-kb HAL2 gene fragment spanning −4.4 kb to +79 bp (relative to the putative transcription start site at +1), was cloned in front of the coding region for EGFP \[[Fig. 5(a)](#F5){ref-type="fig"}\]. The second promoter, the lens-specific *γ*-crystallin gene promoter, was used to drive the expression of GFP3 ([@B36]) \[[Fig. 5(a)](#F5){ref-type="fig"}\]. Using this double promoter construct, we generated F~0~ transgenic animals via the sperm-mediated transgenic procedure ([@B53]). Sexually mature adult F~0~ frogs were used to produce homogeneous transgenic (with their eyes having green fluorescence under ultraviolet) and wild-type (with no fluorescent eyes) sibling tadpoles. When the animals reached premetamorphic stage 54, they were treated with 10 nM T3 for 0 to 5 days to induce precocious metamorphosis, including intestinal remodeling. Total intestinal RNA was isolated from the tadpoles and subjected to qRT-PCR analysis of the expression of the endogenous HAL2 as well as the transgenic EGFP. As shown in [Fig. 5(b)](#F5){ref-type="fig"}, the HAL2 mRNA was absent in the premetamorphic intestine at stage 54 in both wild-type and transgenic tadpoles but was strongly induced after 3 to 5 days of T3 treatment. The same pattern of expression was observed for the transgenic EGFP in the transgenic tadpoles after T3 treatment \[[Fig. 5(c)](#F5){ref-type="fig"}\]. As expected, no EGFP mRNA was detected in the wild-type siblings throughout the treatment \[[Fig. 5(c)](#F5){ref-type="fig"}\]. Thus, the HAL2 promoter was responsive to T3 treatment in the same manner as the endogenous HAL2 gene.

![The transgenic HAL2 promoter, driving EGFP in transgenic tadpoles, respond to T3 similarly as the endogenous HAL2 gene in the intestine. (a) The double promoter transgenic construct used to study the HAL2 promoter *in vivo*. The HAL2 promoter fragment flanked by the *Kpn*I and *Age*I restriction sites \[with the numbers indicating the position relative to the transcription start site in [Fig. 1(a)](#F1){ref-type="fig"}\] was cloned to drive the expression of EGFP in a double promoter transgenic construct, which also contains an eye-specific promoter, the *γ*-crystallin promoter, driving the expression of the GFP3 ([@B36]). The HAL2 TRE in the promoter is shown as an open box. (b and c) Stage 54 premetamorphic wild-type or transgenic tadpoles were treated with 10 nM T3 for 0 to 5 days and total intestinal RNA was isolated for expression analysis of the endogenous HAL2 mRNA (b) or transgenic EGFP mRNA (c). Note that the endogenous HAL2 expression was upregulated significantly after 3 to 5 days of treatment in both wild-type and transgenic tadpoles. The expression of the transgenic EGFP mimicked that of the endogenous HAL2 in the transgenic tadpoles but was, as expected, absent in the wild-type tadpoles.](en.2016-1558f5){#F5}

We next investigated the activity of the transgenic HAL2 promoter during natural metamorphosis. As shown previously, in the wild-type tadpoles, the endogenous HAL2 gene was not expressed in premetamorphic intestine and was strongly upregulated at climax of metamorphosis when adult intestinal stem cells are developing and proliferating (stages 60 to 62) ([@B1]) \[[Fig. 6(a)](#F6){ref-type="fig"}\]. The same pattern was observed for the endogenous HAL2 genes in the transgenic animals during intestinal metamorphosis, again as expected \[[Fig. 6(a)](#F6){ref-type="fig"}\]. Importantly, the expression of the transgenic EGFP under the control of the HAL2 promoter was also found to be regulated in a similar fashion as the endogenous HAL2 mRNA during development in the intestine of the transgenic animals \[[Fig. 6(b)](#F6){ref-type="fig"}\]. To confirm that the HAL2 promoter is specific to the intestinal epithelium at the climax of metamorphosis, we analyzed the expression of the EGFP in the intestines of transgenic tadpoles at the climax by *in situ* hybridization and observed strong signals in the intestinal epithelium with the antisense EGFP probe \[[Fig. 6(c)](#F6){ref-type="fig"}\] but not the sense probe \[[Fig. 6(c)](#F6){ref-type="fig"}\]. Thus, the 4.4-kb promoter region not only responds to T3 *in vivo* but also reproduces the spatiotemporal expression pattern during intestinal metamorphosis. These results suggest that the promoter region contains all critical regulatory elements of the HAL2 gene for its expression and regulation in the intestine during development.

![The expression of the transgenic EGFP under the control of the HAL2 promoter mimics that of the endogenous gene in the intestine during natural metamorphosis. (a and b) RT-PCR analysis shows similar temporal expression patterns of the endogenous HAL2 and transgenic EGFP during development. Total intestinal RNA was isolated from wild-type or sibling transgenic tadpoles at indicated stages throughout metamorphosis and subjected to qRT-PCR analysis for expression of the endogenous HAL2 mRNA (a) or transgenic EGFP mRNA (b). Note that a similar pattern was observed for the EGFP and endogenous HAL2 expression in the transgenic tadpoles. (c and d). *In situ* hybridization confirms the epithelium-specific expression of the transgenic EGFP. The intestinal cross-sections from transgenic tadpoles at the climax of metamorphosis were used for *in situ* hybridization with an antisense (c) or sense probe (d) for EGFP which was visualized with 5-bromo-4-chloro-3-indolyl-phosphate/nitro blue tetrazolium staining (magnification ×200). Note that the transgenic EGFP was detected in the epithelium with an antisense RNA probe for EGFP (c) but not with the sense probe (d). Ct, connective tissue; Ep, epithelium; Lu, lumen; M, muscle.](en.2016-1558f6){#F6}

Discussion {#s16}
==========

Adult organ-specific stem cells are essential for the homeostasis of adult organs and tissue repair and regeneration. The life-long self-renewal of the intestinal epithelium through the proliferation of the adult stem cells has made intestine a valuable model for studying the function and properties of adult stem cells. Extensive studies in mammals have revealed several signaling pathways important for adult intestinal stem cells and contributed to our understanding of intestinal homeostasis and neoplasia ([@B54]). However, the molecular mechanisms regulating the formation of the adult stem cells during development are poorly understood. Intestinal remodeling during *Xenopus* metamorphosis offers a unique opportunity to investigate adult stem cell development due to the *de novo* formation of the adult stem cells during a process that is T3-dependent and easily manipulated, especially with the development of gene editing tools for *Xenopus* studies ([@B3]). Furthermore, intestinal remodeling resembles the maturation of the mouse intestine in the first 3 weeks or so after birth ([@B3]), the postembryonic developmental period when T3 level peaks ([@B7]). Additionally, molecular and genetic studies have suggested that the formation of the mammalian adult intestine is dependent on T3 ([@B25]). Alternatively, little is known about how T3 regulates the formation of adult intestinal stem cells in mammals due to the difficulty to manipulate the mammalian embryos and neonates.

Earlier studies by us and others on intestinal remodeling during amphibian metamorphosis have revealed that the adult intestinal stem cells are formed *de novo* via T3-induced dedifferentiation of larval epithelial cells and led to the identification of many candidate stem cell genes, including the HAL2 gene in *X. laevis* ([@B17]). Expression analyses have revealed that *X. laevis* HAL2 is induced by T3 during intestinal metamorphosis and that its mRNA only expressed during the period of adult stem cell development and proliferation in the intestine during development ([@B26]). Specifically, HAL2 mRNA is present at high levels only in the proliferating adult stem cells at the climax of metamorphosis. In this study, we have shown that HAL2 expression during intestinal development is conserved between *X. laevis* and *X. tropicalis*. Furthermore, we have taken advantages of both the available genomic sequence information in *X. tropicalis* and sperm-nucleus--mediated transgenesis to show that this T3-dependent expression of HAL2 during intestinal remodeling is mediated by a TRE located upstream of the coding region and that a 4-kb promoter fragment can faithfully mimic the endogenous HAL2 promoter to drive a reporter gene expression in transgenic tadpoles.

The HAL2 TRE is highly homologous to the consensus TRE made of two direct repeats of AGGTCA separated by 4 bp \[note that AGGTCA repeats are on the bottom strand in the HAL2 promoter region, [Figs. 2(a)](#F2){ref-type="fig"} and [2(b)](#F2){ref-type="fig"}\]. Only the last three bases of the second half site, which are less critical for TR binding, were changed from TCA to TTG. Not surprisingly, we observed that the HAL2 TRE binds to TR/RXR heterodimers with strong affinity *in vitro*, comparable to the well-studied, strong TRE of *X. laevis* TR*β* gene \[[Fig. 2(c)](#F2){ref-type="fig"}\] ([@B50]). The HAL2 TRE also functioned similarly in the frog oocyte *in vivo* transcription system to mediate the transcriptional regulation by T3 in the presence of TR/RXR \[[Fig. 3(b)](#F3){ref-type="fig"}\]. Furthermore, the TRE is bound by TR in the intestine during development when HAL2 gene is inducible by T3 treatment. (Note that weak binding of TR to the TRE was observed in the premetamorphic tadpole intestine in the absence of T3 when there were not adult epithelial cells. It is possible that there is weak binding of TR to the TRE in the larval epithelial cells or other cells in the intestine and this weak binding alone is not sufficient for the induction of the gene in these cells.) More importantly, a promoter fragment containing the TRE faithfully reproduced the developmental regulation pattern of the endogenous HAL2 genes in transgenic animals ([Fig. 6](#F6){ref-type="fig"}). These findings strongly argue that the HAL2 gene is a direct target gene of T3 and is regulated via TR binding to the TRE during intestinal metamorphosis.

Although our data indicate that T3 directly activates the HAL2 promoter via TR/RXR binding to the HAL2 TRE, the kinetics of the T3 induction were slow for both the transgenic EGFP and endogenous HAL2 mRNAs, as significant induction was observed only after 3 to 5 days of T3 treatment ([Fig. 5](#F5){ref-type="fig"}). Similarly, during natural metamorphosis, high levels of transgenic EGFP and endogenous HAL2 mRNAs were observed at stage 60 or later, the climax of metamorphosis, whereas only low levels were present up to stage 58, the onset of metamorphic climax ([Figs. 1](#F1){ref-type="fig"} and [6](#F6){ref-type="fig"}). There are several possibilities for this delay in T3 induction. First and most likely, HAL2 is only expressed at high levels in the adult stem cell ([@B26]). At an early stage of metamorphosis, up to stage 60, or during the first few days of T3 treatment of premetamorphic tadpoles, there are few stem cells present in the tadpole intestine. Thus, the overall HAL2 expression in the whole intestine would be low until the fraction of cells that are adult stem cells increases significantly. In support of this, a similar kinetics was reported for another stem cell--specific, direct T3 target gene, the AMDHD1 gene, which encodes another enzyme in the histidine catabolic pathway ([@B40]). Alternatively, the products of one or more T3-induced genes are involved to further enhance HAL2 induction by T3. Thus, in the early phase of T3 treatment or natural metamorphosis, the HAL2 levels would be low but, subsequently, as these products accumulate during development or T3 treatment, HAL2 expression is further increased.

HAL2 is specifically expressed in the developing/proliferating adult intestinal stem cells during metamorphosis. Our findings showing that HAL2 is a direct target gene of TR suggest that HAL2 is induced early during the formation of the adult stem cells. We have shown previously that the adult stem cells are formed from dedifferentiation of some larval epithelial cells ([@B16]). It remains to be determined how and why these larval epithelial cells undergo dedifferentiation instead of T3-induced apoptosis, the fate of most of the larval epithelial cells ([@B5]). It is possible that the activation of the HAL2 gene in the larval epithelial cells represents one of the early events that help the cells to choose the dedifferentiation fate instead of programmed cell death when T3 becomes available during metamorphosis.

HAL2 encodes histidase, also known as histidinase, the first enzyme in the histidine catabolism pathway, that is, the deamination of histidine to ammonia and urocanic acid ([@B27]). It is possible that the direct product of the HAL2 catalysis, urocanic acid, or other products of the histidine catabolic pathway are involved in stem cell development. This would resemble the requirement of threonine catabolism for mouse embryonic stem cells ([@B68]). Additionally, the ultimate product of the histidine catabolic pathway, glutamate, can affect the activity of mammalian target of rapamycin complex 1 (mTORC1; also known as mechanistic target of rapamycin complex 1) ([@B69]). The mTORC1 complex functions as a nutrient/energy/redox sensor and controls protein synthesis, thus affecting cell fate and function ([@B71]). Given the lack of feeding during metamorphosis, it is possible that mTORC1 mediates the effect of HAL2 on adult stem cell formation/proliferation.

Our transgenic studies indicate that the HAL2 promoter fragment mimics the endogenous HAL2 promoter to drive the reporter EGFP expression during intestinal remodeling in transgenic animals. This represents the first *Xenopus* promoter that is active specifically in the developing/proliferating adult epithelial stem cells during metamorphosis. It should be possible in the future to use the promoter to drive the expression of wild-type or mutant genes, such as dominant-negative or dominant-positive TR ([@B73]), specifically in the stem cells to study their stem cell--specific function during development.

Abbreviations: ChIPchromatin immunoprecipitationEF1*α*elongation factor-1*α*EGFPenhanced green fluorescent proteinGFPgreen fluorescent proteinHALhistidine ammonia-lyasemRNAmessenger RNAmTORC1mammalian target of rapamycin complex 1PCRpolymerase chain reactionqRT-PCRquantitative reverse transcription--polymerase chain reactionRXR9-*cis* retinoic acid receptorT3thyroid hormoneTRthyroid hormone receptorTREthyroid hormone response element.
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